Justine Bruce is Professor (CHS) at University of Wisconsin–Madison. OpenAlex indexes 217 publications with 7,293 citations (h-index 23); ClinicalTrials.gov lists 11 registered studies with this person as an investigator.
Data verified 22 Oct 2026
Overview
Updated 22 Oct 2026
Justine Bruce is Professor (CHS) at University of Wisconsin–Madison. The public record shows 217 publications with 7,293 citations (h-index 23), centered on Head and Neck Cancer Studies, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 6 companies, 1 NIH-funded awards (2021–2026).
- Most recent indexed publication: 2026 · Cancer research communications
- Top research focus: Head and Neck Cancer Studies
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 22 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 12 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 36.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 22 Oct 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer
Sponsor: University of Wisconsin, Madison
- Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Sponsor: National Cancer Institute (NCI)
- Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma
Sponsor: University of Wisconsin, Madison
Industry payments
Updated 22 Oct 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20257 payments
- GENZYME CORPORATIONProgram year20241 payment
- Coherus Biosciences Inc.Program year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
33.5%Phenothiazine21.4%Prochlorperazine Maleate100%Part D≥28 patientsAtypical Antipsychotic12.1%Olanzapine100%Part D≥18 patientsMetabolism & gastrointestinal
31.1%Serotonin-3 Receptor Antagonist25.7%Ondansetron Hcl100%Part D≥30 patientsPotassium supplement5.3%Potassium Chloride100%Part D<11 patientsHormonal (systemic)
17%l-Thyroxine17%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 22 Oct 2026
1 NIH research award on record, funded 2021–2026 per NIH RePORTER. The latest:
Congress activity
Updated 22 Oct 2026
49 congress contributions (2008–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 22 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Window-of-Opportunity Study Utilizing Preoperative Cetuximab in Patients with Head and Neck Cancer.
Cancer research communications
Article2026 - Enfortumab Vedotin plus Pembrolizumab as First-line Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Results from EV-202 Cohort 9.
Clinical cancer research
Clinical Trial2026 - Reply to: Enfortumab Vedotin: A Promising Therapy for Head and Neck Cancer With Potential Links to Human Papillomavirus.
Journal of clinical oncology
Article2025
Most-cited works
by citation count (OpenAlex)- 01
- 02Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyArticle1,362 citations2020
- 03Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in OncologyArticle624 citations2019
- 04NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022Article527 citations2022
- 05NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025Article197 citations2025
Network
Updated 22 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 22 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/justine-bruce-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
hn-spore.wisc.edu/team_member/bruce
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hn-spore.wisc.edu ↗ - Other
medicine.wisc.edu/directory/bruce-justine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.wisc.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 22 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hn-spore.wisc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hn-spore.wisc.edu ↗
- MD
University of Texas Southwestern Medical Center, Dallas, Texas
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uwhealth.org ↗
Editorial & leadership roles
journal and society appointments- Member
Cancer Therapy Discovery and Development Program, University of Wisconsin Carbone Cancer Center
2008verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hn-spore.wisc.edu ↗ - Chair of the Protocol Review and Monitoring Committee
University of Wisconsin Carbone Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - Member
American Society of Clinical Oncology (ASCO)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - Member
Eastern Cooperative Oncology Group (ECOG)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - Member
National Comprehensive Cancer Network (NCCN)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - Member
Big Ten Cancer Research Consortium (BTCRC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗
- Co-leader
Project 3, Wisconsin Head and Neck SPORE
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hn-spore.wisc.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Mark Albertini, MD
University of Wisconsin–Madison
Bryn Webb, MD
University of Wisconsin–Madison
Jeannina Smith, MD
University of Wisconsin–Madison
Carolina Pusec, PhD, MD
University of Wisconsin–Madison
Neal Futran, MD
University of Washington (UW Medicine)
Everett Vokes, MD
University of Chicago
Maura Gillison, MD
The University of Texas MD Anderson Cancer Center
Antonio Jimeno, MD
University of Colorado Cancer Center